Shingles - Page 6

Localization – Where does post-zoster neuralgia occur particularly frequently? | Post-Zoster Neuralgia

Localization – Where does post-zoster neuralgia occur particularly frequently? Post-zoster neuralgia usually initially has a specific localization, which depends on which nerves or in which cell bodies of the nerves the herpes viruses have dwelt after the chickenpox infection. Depending on this, the pain then occurs in a specific area that is supplied by the … Localization – Where does post-zoster neuralgia occur particularly frequently? | Post-Zoster Neuralgia

In what order do the symptoms appear? | Course of shingles

In what order do the symptoms appear? The order of symptoms is usually very similar. Often, pain initially occurs in the affected body part without visible skin changes. Pain is thus produced in the affected dermatome. This means that the skin area supplied by the affected nerve cord is painful. Some affected persons also report … In what order do the symptoms appear? | Course of shingles

Duration | Course of shingles

Duration The “incubation period” takes decades. The time before the outbreak of the rash usually lasts a few days. The appearance of the general symptoms is evident during this time. The first skin symptoms appear as redness and remain for a few days. When the first skin changes are visible, the formation of blisters on … Duration | Course of shingles

Course of shingles

Introduction The course of shingles is characterized by different phases. After a kind of “incubation period” of decades, shingles develops in two phases. The first phase is characterized by general symptoms. In this phase, no skin symptoms are yet visible. Depending on where the shingles has manifested itself in the body, various misinterpreted symptoms can … Course of shingles

Zostavax® vaccination against shingles

Introduction – What is a Zostavax® vaccination? The Zostavax® vaccination is a vaccine approved in 2006 and available in Germany since 2013. It is intended to prevent the development of a girdle-rose (Herpes Zoster infection). In Germany, vaccination against Varicella zoster (chickenpox) in children has been recommended since 2004. The Zostavax® vaccination is aimed at … Zostavax® vaccination against shingles

What effect can be expected? | Zostavax® vaccination against shingles

What effect can be expected? The active ingredient in the Zostavax® vaccine is live Varicella zoster pathogens. These are no longer capable of causing an infection. These are attenuated forms of the pathogens – so-called attenuated pathogens. However, in persons whose immune system is no longer adequately functional, this live vaccine could lead to the … What effect can be expected? | Zostavax® vaccination against shingles

Dosage of the vaccine | Zostavax® vaccination against shingles

Dosage of the vaccine The dosage is specified by the manufacturer. The inoculation solution (0.65ml) is available on the market as a ready-made solution or powder. It contains at least 19. 400 PBE (plaque forming units). This means the number of effective or active pathogens. The concentration in the Zostavax® vaccine is up to 14 … Dosage of the vaccine | Zostavax® vaccination against shingles